TGFB1 and colorectal cancer: In fact, a very recent study in colorectal cancer has demonstrated that the administration of TGF-β inhibitor eliminates TGF-β-mediated immunosuppressive effects on the immune system, thereby enhancing immunotherapy efficiency [108].